DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Dominic Tabor, Dermatology Registrar, Royal Infirmary of Edinburgh, Scotland. Chief Editor: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, October 2015.
Waardenburg syndrome is a rare genetic disorder characterised by deafness and abnormal pigmentation, such as:
Waardenburg syndrome may also be associated with musculoskeletal defects and Hirschsprung syndrome.
Waardenburg syndrome is named after Petrus Johannes Waardenburg, a Dutch ophthalmologist, who noticed that heterochromia iridis often accompanied deafness.
Waardenburg syndrome may be inherited or may arise spontaneously. It affects men and women equally, and can affect all races.
It has a population frequency of 1 in 42,000, and is responsible for 1–3% of all cases of congenital deafness.
Waardenburg syndrome is thought to be a neurocristopathy. It is the result of abnormal neural crest differentiation during embryonic development.
Several different gene mutations can cause Waardenburg syndrome, leading to some differences in signs and symptoms. Expression and penetrance are also variable.
Several types of mutation can cause Waardenburg syndrome – insertions, deletions, frameshifts, splice alterations, missense, or nonsense mutations.
Most types of Waardenburg syndrome are autosomal dominant, meaning that only one affected gene needs to be passed on to a child for them to have the syndrome. Transmission of defects in EDN3 or EDNRB is more complex. They are usually autosomal recessive, although cases of autosomal dominant transmission with incomplete penetrance have been described.
Other mutations in some of the above genes can cause related clinical syndromes, such as Tietz syndrome (MITF gene), piebaldism (SNAI2 gene), PCWH (SOX10 gene), or ABCD syndrome (EDNRB gene).
Features are present from birth. As it is a rare condition and clinical signs can be subtle, diagnosis may not be made until later in life.
Four major clinical subtypes of Waardenburg syndrome have been identified.
Type 1 is the most common subtype of Waardenburg syndrome. Features include:
Type 2 has similar clinical features to type 1 Waardenburg syndrome, but the inner canthi are normal.
Type 3 (Klein-Waardenburg syndrome) also has similar features to type 1 Waardenburg syndrome, but with musculoskeletal abnormalities, such as muscle hypoplasia, flexion contractures or syndactyly (fused digits).
Type 4 (Shah-Waardenburg syndrome) has similar features to type 2 Waardenburg syndrome but with Hirschsprung syndrome (a condition resulting from missing nerve cells in the muscles of part or all of the large intestine).
The diagnosis of Waardenburg syndrome is based on clinical features. In 1992 the Waardenburg Consortium developed major and minor criteria for diagnosis.
A clinical diagnosis of type 1 Waardenburg syndrome needs 2 major, or 1 major and 2 minor criteria.
The W index can be calculated to determine whether dystopia canthorum is present.
Genetic sequencing of the PAX3 gene for mutations causing Waardenburg syndrome may be performed as part of genetic counselling of family members. Prenatal testing for PAX3 mutations is possible by chorionic villus sampling or amniocentesis, but is rarely done. This is because of the clinical variation found within Waardenburg syndrome, since the presence of the mutation will not indicate which clinical features will be present, or their severity.
There is no direct treatment for Waardenburg syndrome itself, and as it is a genetic condition there is no cure. Genetic counselling may be beneficial for affected patients who want to start a family.
Waardenburg syndrome is a chronic condition and the features will remain throughout life. Life expectancy is normal.
See the DermNet NZ bookstore.
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.